Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.
We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 1901 W. 47th Place, Suite 310,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.cingulate.com/
- HQ
- Kansas City, Kansas
Cingulate Inc. Questions
Cingulate Inc.'s website is https://www.cingulate.com/
Cingulate Inc.'s LinkedIn profile is https://www.linkedin.com/company/cingulateinc
Cingulate Inc. has
20 employees.
View email and phone details for 20
employees at Cingulate Inc..
Cingulate Inc.'s industry is
Pharmaceutical Manufacturing
Cingulate Inc.'s top competitors are
Arovella Therapeutics Asx: Ala,
Oncolytics Biotech Inc.,
Spinogenix, Inc.,
Bioxcel Therapeutics, Inc.,
Caidya,
Navipoint Health, Inc.,
Cingulate Therapeutics,
Processa Pharmaceuticals,
Mira Pharmaceuticals,
Active Biotech Ab.
Cingulate Inc.'s categories are Pharmaceutical Manufacturing
Cingulate Inc.'s founding year is 2012
